Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Gain Therapeutics (GANX) Leases (2020 - 2025)

Gain Therapeutics has reported Leases over the past 6 years, most recently at $184422.0 for Q3 2025.

  • Quarterly results put Leases at $184422.0 for Q3 2025, down 34.5% from a year ago — trailing twelve months through Sep 2025 was $184422.0 (down 34.5% YoY), and the annual figure for FY2024 was $219715.0, down 52.15%.
  • Leases for Q3 2025 was $184422.0 at Gain Therapeutics, down from $233200.0 in the prior quarter.
  • Over the last five years, Leases for GANX hit a ceiling of $901042.0 in Q4 2021 and a floor of $183664.0 in Q1 2025.
  • Median Leases over the past 5 years was $499017.0 (2021), compared with a mean of $515764.8.
  • Biggest five-year swings in Leases: soared 72.26% in 2021 and later plummeted 52.19% in 2025.
  • Gain Therapeutics' Leases stood at $901042.0 in 2021, then fell by 26.76% to $659933.0 in 2022, then crashed by 30.41% to $459215.0 in 2023, then plummeted by 52.15% to $219715.0 in 2024, then fell by 16.06% to $184422.0 in 2025.
  • The last three reported values for Leases were $184422.0 (Q3 2025), $233200.0 (Q2 2025), and $183664.0 (Q1 2025) per Business Quant data.